2.550
2.55 (0%)
As of Dec 24, 2024
Vistagen Therapeutics, Inc. [VTGN]
Source:
Company Overview
Vistagen Therapeutics, Inc. is a neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on our deep understanding of nose-to-brain neurocircuitry.
| Country | United States |
| Headquarters | san francisco, california |
| Phone Number | (650) 577-3600 |
| Industry | manufacturing |
| CEO | Shawn K. Singh |
| Website | www.vistagen.com |